The global clinical nutrition market size was valued at $313.578 billion in 2018, and is projected to reach $552.503 billion by 2026, growing at a CAGR of 5.3% from 2019-2026. Clinical nutrition product is a type of pharmaceutical product that helps to keep a patient healthy. It helps to improve the metabolic system by providing adequate supplements such as minerals, vitamins, and others. Clinical nutrition diagnose and treat diseases that affect the intake, intestinal absorption, and metabolism of constituents of the diet, and help promote health through prevention of diet-related diseases. It works in both acute and ambulatory care settings, which includes cardiac rehabilitation, renal dialysis, diabetes, pediatrics, nutrition support, cancer, trauma, wellness centers, and community-based intervention programs.
There is an increase in the demand for clinical nutrition owing to increase in chronic and lifestyle related disease such as inflammatory bowel disease and diabetes mellitus. Furthermore, rise in geriatric population and rise in population of a baby boomers further contributes to the market growth. Moreover, rise in R&D investments made by government in the healthcare sector drives the growth of the clinical nutrition market. However, lack of awareness and stringent regulations restrain the market growth. On the contrary, rise in advancements in clinical nutrition. Further, rise in demand of the clinical nutrition in the emerging countries such as Asia-Pacific and LAMEA and increase in home care usage of the nutritional products are expected to offer lucrative opportunities for the global clinical nutrition market players.
The global clinical nutrition market is segmented on the basis of route of administration, application, end user, and region. By route of administration, the market is classified into oral, enteral, and parenteral. On the basis of application, the market is categorized into cancer, neurological diseases, gastrointestinal disorders, metabolic disorders, and others. By end user, the market is segmented into pediatric, adults, and geriatric. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
There is an increase in the demand for clinical nutrition owing to increase in chronic and lifestyle related disease such as inflammatory bowel disease and diabetes mellitus. Furthermore, rise in geriatric population and rise in population of a baby boomers further contributes to the market growth. Moreover, rise in R&D investments made by government in the healthcare sector drives the growth of the clinical nutrition market. However, lack of awareness and stringent regulations restrain the market growth. On the contrary, rise in advancements in clinical nutrition. Further, rise in demand of the clinical nutrition in the emerging countries such as Asia-Pacific and LAMEA and increase in home care usage of the nutritional products are expected to offer lucrative opportunities for the global clinical nutrition market players.
The global clinical nutrition market is segmented on the basis of route of administration, application, end user, and region. By route of administration, the market is classified into oral, enteral, and parenteral. On the basis of application, the market is categorized into cancer, neurological diseases, gastrointestinal disorders, metabolic disorders, and others. By end user, the market is segmented into pediatric, adults, and geriatric. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Stakeholders
- This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019-2026, which assists to identify the prevailing market opportunities.
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the global clinical nutrition market is provided.
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
By Route Of Administration
- Oral
- Enteral
- Parenteral
By Application
- Cancer
- Neurological Diseases
- Gastrointestinal Disorders
- Metabolic Disorders
- Others
By End User
- Pediatric
- Adults
- Geriatric
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- Spain
- Italy
- UK
- Rest of Europe
- Asia-Pacific
- Japan
- India
- China
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- Abbott Laboratories
- B. Braun Melsungen AG
- Danone Nutricia
- Baxter International Inc.
- Fresenius SE & Co. KGaA
- Perrigo Company Plc
- Pfizer Inc
- Nestlé S.A
- Lonza Ltd
- Hero Nutritionals Inc
- Quantel laser
- Nidek CO., LTD.
- Topcon Corporation
- DEKA M.E.L.A. S.r.l.
- SharpLight Technologies
- Sciton, Inc.
- Alma Lasers
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION
CHAPTER 5: CLINICAL NUTRITION MARKET, BY APPLICATION
CHAPTER 6: CLINICAL NUTRITION MARKET, BY END USER
CHAPTER 7: CLINICAL NUTRITION MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report titled, 'Clinical Nutrition Market by Route of Administration, Application, and End User: Opportunity Analysis and Industry Forecast, 2019-2026', the global clinical nutrition market size was $31.3 billion in 2018, and is projected to reach $55.2 billion by 2026, growing at a CAGR of 5.3% from 2019 to 2026. Clinical nutrition deals with the basic knowledge, diagnosis, and treatment of disease related to the nutritional deficiency that affect the intestinal absorption, and metabolism of a person. The clinical nutritionists generally work in both acute and ambulatory care settings for many diseases such as cancer, cardiac rehabilitation, renal dialysis, and diabetes.The clinical nutrition market is expected to exhibit significant growth during the forecast period due to increase in prevalence of chronic disorders & lifestyle-related disorders and rise in number of patients using advanced clinical nutritional products globally. In addition, rise in R&D investments made by the government in healthcare are the major factors that boost the global clinical nutrition market. However, lack of awareness and stringent regulations are projected to impede market growth. Moreover, rise in advancement of clinical nutrition and rise in demand of the clinical nutrition in the emerging countries such as Asia-Pacific and LAMEA are expected to offer significant profitable opportunities for the manufacturers in the global clinical nutrition market.
Based on route of administration, the oral segment accounted for the largest share in 2018, and is anticipated to continue this trend during the forecast period. This is attributed to its wider usage and applications and due to its easy intake for many diseases.
Based on end user, the pediatric segment accounted for the largest share in 2018, and will continue the trend during the forecast period. This is attributed to increase in concern of malnutrition in pediatric patients.
Region wise, Asia-Pacific is expected to be the fastest growing region during the forecast period for clinical nutrition market, owing to increase in geriatric population, rise in metabolic and chronic disorders, high disposable incomes, and rise in awareness toward the adoption of clinical nutrition products.
The report provides a comprehensive analysis of the key players operating in the global clinical nutrition market, which include Abbott Laboratories, B. Braun Melsungen AG, Danone Nutricia, Baxter International Inc., Fresenius SE & Co. KGaA, Perrigo Company Plc, Pfizer Inc, Nestlé S.A, Lonza Ltd, and Hero Nutritionals Inc. The other players in the value chain (companies not included in the report) include Ajinomoto Co. Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, and H. J. Heinz Company.
Key Findings of the Study:
Based on application, the oral segment is expected to be the experience a fast growth during the forecast period.
By application, the cancer segment accounted for the largest share in 2018, and is anticipated to continue this trend during the forecast period.
Depending on end user, the pediatric segment is expected to exhibit the highest CAGR with 6.0% during the forecast period.
U.S. generated the highest revenue in the global clinical nutrition market in 2018, accounting for more than two-fifths share of the global market.
Asia-Pacific is estimated to grow at the highest CAGR of 6.0% during the forecast period.
Companies Mentioned
- Abbott Laboratories
- B. Braun Melsungen AG
- Danone Nutricia
- Baxter International Inc.
- Fresenius SE & Co. KGaA
- Perrigo Company Plc
- Pfizer Inc.
- Lonza Ltd
- Nestlé S.A.
- Hero Nutritionals Inc
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
